Vivus says victim of false statements, delays shareholder meet
(Reuters) - U.S. drugmaker Vivus Inc, locked in a proxy battle with top investor First Manhattan Co, said FMC's advisers had made false statements to ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/u2fJ3PLrylE/story01.htm
No comments:
Post a Comment